Committed to Interventional Oncology
Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide.
TheraSphere receives FDA Approval!
After 20 years as a humanitarian exemption device (HDE), the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 therapy indicated for HCC. This means institutional review board (IRB) approval of TheraSphere is no longer required by the FDA.
Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Supported by robust clinical evidence, Ranger provides exceptional outcomes, effortless deliverability, and efficient drug transfer.
Resources for patients and healthcare professionals.
View and download the coronary and peripheral vascular product catalogs.
Talk to a representative
Want to learn more about products and services? One of our sales representatives will be happy to contact you.
Stay up-to-date with emails on the latest advances, news and innovations in interventional radiology.